Revaprazan Hydrochloride

็›้…ธ็‘žไผๆ‹‰่ตž

Report date: 2023/03/15 17:56:26
NME

Base Information

Drug NameRevaprazan Hydrochloride
Drug Alias Namerevaprazanum็›้…ธ็‘žๆ™ฎๆ‹‰็”ŸRevanexSB-641257SB-641257A +[7]ย 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium-transporting ATPase inhibitors
TargetsPotassium-transporting ATPase
Therapy Area/IndicationsStomach UlcerDuodenal UlcerGastritis +[4]ย 
Global Approved IndicationsStomach UlcerDuodenal UlcerGastritis
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2005/09/01
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesYuhan Corp
China Registration ClassN/A

Develop Information

Active CompaniesYuhan Corp
Inactive CompaniesN/A
Active IndicationsStomach UlcerDuodenal UlcerGastritis
Inactive IndicationsGastroesophageal Reflux

Other Information

ATC CodeA02B
Related LinksWikipediaKEGG